COVID-19 and Its Impact on Upper Gastrointestinal (GI) Cancer Management

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2021 Jan 26

PMID 33494406

Citations 5

Authors

Shalini Fernando

Mesel Veli

Borzoueh Mohammadi

Andrew Millar

Khurum Khan

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19), caused by the novel, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has left dramatic footprints on human health and economy. Cancer, whilst not an infective disease, is prevalent in epidemic proportions and cannot be pretermitted due to the impact of COVID-19. As we emanate from the second national lockdown in the UK with mixed feelings of hope and despair-due to vaccination and new COVID-19 variant, respectively-we reflect on the impact of the first wave on the provision on diagnosis and management of with upper gastrointestinal (UGI) cancers. This review provides a critical analysis of available literature on COVID-19 and its impact on cancer management in general and that of UGI cancers in particular.

Citing Articles

The Effect of Coronavirus Disease 2019 on the Quality of Associated Care in Patients with Gastric Cancer.

Omidifar N, Pazoki N, Shokripour M, Fattahi M, Safarpour A, Fallahzadeh Abarghooee E Middle East J Dig Dis. 2024; 16(1):12-22.

PMID: 39050096 PMC: 11264831. DOI: 10.34172/mejdd.2024.363.

Impact of the COVID-19 pandemic on esophageal cancer resource allocation: a systematic review.

Fialka N, El-Andari R, Jogiat U, Bedard E, Laing B, Nagendran J J Thorac Dis. 2024; 16(2):1576-1589.

PMID: 38505032 PMC: 10944786. DOI: 10.21037/jtd-23-1232.

Exploring the association between COVID-19 and male genital cancer risk in European population: evidence from mendelian randomization analysis.

Wang D, Ma Y, Yan L, Gan W, Han Y, Tan J BMC Genom Data. 2023; 24(1):56.

PMID: 37749495 PMC: 10521436. DOI: 10.1186/s12863-023-01158-x.

Impact of Covid-19 on gastrointestinal cancer surgery: A National Survey.

Parray A, Chaudhari V, Bhandare M, Madhabananda K, Muduly D, Sudhindran S Langenbecks Arch Surg. 2022; 407(8):3735-3745.

PMID: 36098808 PMC: 9469820. DOI: 10.1007/s00423-022-02675-6.

Impact of COVID-19 on the outcomes of gastrointestinal surgery.

Gupta R, Gupta J, Ammar H Clin J Gastroenterol. 2021; 14(4):932-946.

PMID: 33928515 PMC: 8083095. DOI: 10.1007/s12328-021-01424-4.

References

Lee R, Wysocki O, Zhou C, Shotton R, Tivey A, Lever L . Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital. JCO Clin Cancer Inform. 2022; 6:e2100177. PMC: 9173569. DOI: 10.1200/CCI.21.00177. View

Crolley V, Hanna D, Joharatnam-Hogan N, Chopra N, Bamac E, Desai M . COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study. Ther Adv Med Oncol. 2020; 12:1758835920971147. PMC: 7592172. DOI: 10.1177/1758835920971147. View

Wang Z, Wang J, He J . Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China. JAMA Oncol. 2020; 6(5):631-632. DOI: 10.1001/jamaoncol.2020.1198. View

Doran S, Patel P, Chaudry A, Pollok J, Kumar S, Bhogal R . COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience. Eur J Surg Oncol. 2020; 46(6):1198-1199. PMC: 7186123. DOI: 10.1016/j.ejso.2020.04.045. View

Yu J, Ouyang W, Chua M, Xie C . SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020; 6(7):1108-1110. PMC: 7097836. DOI: 10.1001/jamaoncol.2020.0980. View

Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K . Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020; 21(7):904-913. PMC: 7259917. DOI: 10.1016/S1470-2045(20)30310-7. View

Sidaway P . COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020; 17(6):336. PMC: 7136993. DOI: 10.1038/s41571-020-0366-2. View

Abdul-Jawad S, Bau L, Alaguthurai T, Del Molino Del Barrio I, Laing A, Hayday T . Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients. Cancer Cell. 2021; 39(2):257-275.e6. PMC: 7833668. DOI: 10.1016/j.ccell.2021.01.001. View

Markar S, Clarke J, Kinross J . Practice patterns of diagnostic upper gastrointestinal endoscopy during the initial COVID-19 outbreak in England. Lancet Gastroenterol Hepatol. 2020; 5(9):804-805. PMC: 7365623. DOI: 10.1016/S2468-1253(20)30236-3. View

10.

Jee J, Foote M, Lumish M, Stonestrom A, Wills B, Narendra V . Chemotherapy and COVID-19 Outcomes in Patients With Cancer. J Clin Oncol. 2020; 38(30):3538-3546. PMC: 7571792. DOI: 10.1200/JCO.20.01307. View

11.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21(3):335-337. PMC: 7159000. DOI: 10.1016/S1470-2045(20)30096-6. View

12.

Verma A, Nagpal J . Gastrointestinal cancer pathways may breakdown due to COVID-19. Frontline Gastroenterol. 2020; 11(5):413. PMC: 7447284. DOI: 10.1136/flgastro-2020-101569. View

13.

Joharatnam-Hogan N, Khan K . COVID-19 cancer conundrum-evidence driving decisions or the lack of it?. BMC Med. 2020; 18(1):182. PMC: 7282465. DOI: 10.1186/s12916-020-01649-z. View

14.

Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P . Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020; 201(11):1372-1379. PMC: 7258652. DOI: 10.1164/rccm.202003-0543OC. View

15.

Yang F, Shi S, Zhu J, Shi J, Dai K, Chen X . Clinical characteristics and outcomes of cancer patients with COVID-19. J Med Virol. 2020; 92(10):2067-2073. DOI: 10.1002/jmv.25972. View

16.

Pinato D, Zambelli A, Aguilar-Company J, Bower M, Sng C, Salazar R . Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients. Cancer Discov. 2020; . PMC: 7668225. DOI: 10.1158/2159-8290.CD-20-0773. View

17.

Rutter M, Brookes M, Lee T, Rogers P, Sharp L . Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis. Gut. 2020; 70(3):537-543. DOI: 10.1136/gutjnl-2020-322179. View

18.

Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z . Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020; 10(6):783-791. PMC: 7309152. DOI: 10.1158/2159-8290.CD-20-0422. View

19.

Lee L, Cazier J, Angelis V, Arnold R, Bisht V, Campton N . COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020; 395(10241):1919-1926. PMC: 7255715. DOI: 10.1016/S0140-6736(20)31173-9. View

20.

Joharatnam-Hogan N, Hochhauser D, Shiu K, Rush H, Crolley V, Wilson W . Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience. Ther Adv Med Oncol. 2020; 12:1758835920956803. PMC: 7493246. DOI: 10.1177/1758835920956803. View